產(chǎn)品詳情
簡單介紹：
Anti-CD361抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CD361抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CD361
Cat. Number:
Anti-CD361抗體KL-14684R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
EVI2B is a 448 amino acid protein which functions in the differentiation of melanocytes and keratinocytes. Lying within an intron of the Neurofibromin gene, the gene encoding EVI2B is transcribed from the telomereAnti-CD361抗體 toward the centromere, which is opposite the transcription direction of the Neurofibromin gene. EVI2B is a single-pass transmembrane protein containing an extracellular domain with 4 glycosylation sites, a N-terminal signal peptide, a cytoplasmic hydrophilic domain and a hydrophobic transmembrane domain. Due to evidence suggesting that gene encoding the mouse homolog lies within a viral integration site that has been identitified in retrovirus-induced myeloid tumors, the gene encoding EVI2B may function as an oncogene in these tumor types. With expression in peripheral blood mononuclear cells, fibroblasts, bone marrow and EBV-transformed lymphoblastoid cell lines, EVI2B is implicated in leukemogenesis.
Also known as:
EVI2B; CD361; D17S376; Anti-CD361抗體Ecotropic viral integration site 2B; Ecotropic viral integration site 2B protein homolog; EVDB; EVI 2B; EVI-2B; Evi2b; EVI2B protein; EVI2B_HUMAN; Protein EVI2B.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CD361.
●
Predicted Molecular Weight:Anti-CD361抗體 46kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-CD361抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-CD361抗體
Optimal working dilutions must be determined by the end user.
kl380Bo01 血管活性腸肽(VIP)多克隆抗體 Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl380Hu01 血管活性腸肽(VIP)多克隆抗體 Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl380Mu01 血管活性腸肽(VIP)多克隆抗體 Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl380Ra01 血管活性腸肽(VIP)多克隆抗體 Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl382Hu01 蛋白激酶Bγ(PKBγ)多克隆抗體 Polyclonal Antibody to Protein Kinase B Gamma (PKBg)
kl383Hu01 磷酸肌醇-3-激酶2α肽(PI3K2α)多克隆抗體 Polyclonal Antibody to Phosphoinositide-3-Kinase Class-2-Alpha Polypeptide (PIK3C2a)
kl383Mu01 磷酸肌醇-3-激酶2α肽(PI3K2α)多克隆抗體 Polyclonal Antibody to Phosphoinositide-3-Kinase Class-2-Alpha Polypeptide (PIK3C2a)
kl384Hu01 白介素23(IL23)多克隆抗體 Polyclonal Antibody to Interleukin 23 (IL23)
kl384Mu01 白介素23(IL23)多克隆抗體 Polyclonal Antibody to Interleukin 23 (IL23)
kl384Ra01 白介素23(IL23)多克隆抗體 Polyclonal Antibody to Interleukin 23 (IL23)
kl385Hu01 白介素27(IL27)多克隆抗體 Polyclonal Antibody to Interleukin 27 (IL27)
kl385Ra01 白介素27(IL27)多克隆抗體 Polyclonal Antibody to Interleukin 27 (IL27)
kl389Mu01 補(bǔ)體成分4a(C4a)多克隆抗體 Polyclonal Antibody to Complement Component 4a (C4a)
kl389Ra01 補(bǔ)體成分4a(C4a)多克隆抗體 Polyclonal Antibody to Complement Component 4a (C4a)
kl391Hu01 卵泡抑素(FS)多克隆抗體 Polyclonal Antibody to Follistatin (FS)
